Amyotrophic lateral sclerosis, excitotoxicity and riluzole

Author： Obrenovitch T.P.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.1, 1998-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1942-1959

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis

By Messori A.  

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 153-163

Adis International

Access to resources Recommend Favorite

The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

By Bensimon Gilbert   Doble Adam  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 525-534

Informa Healthcare

Access to resources Recommend Favorite

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C   Tovar-y-Romo Luis B   Tapia Ricardo  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

Riluzole Use During Pregnancy in a Patient with Amyotrophic Lateral Sclerosis: a Case Report

By Kawamichi Y   Makino Y   Matsuda Y   Miyazaki K   Uchiyama S   Ohta H  

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 720-726

Field House Publishing

Access to resources Recommend Favorite